Global Neurology Academy

How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiers
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
- John A. Morren, MD, FAAN, FAANEM
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
NeuroFrontiers
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
- Riley Bove, MD, MMSc
CME/CE Meeting
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
July 30, 2025
Toronto
Learn more
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiers
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiers
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiers
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
- Maxwell H. Levy, MD
The Complexities of DMD: Optimizing Multidisciplinary Care
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiers
The Complexities of DMD: Optimizing Multidisciplinary Care
- Rosaline Quinlivan
Reducing the Burden of gMG with a Novel B-Cell Therapy
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS

Medical News

Medical News
Brainwave Modulation Therapies: A New Frontier in Chronic Nerve Pain Management
06/05/2025
Read more
Medical News
Unveiling Altered RNA Processing in ALS: New Targets for Precision Neurodegenerative Therapy
06/05/2025
Read more
Medical News
Integrating Translational Science Breakthroughs in Alzheimer's Care
06/05/2025
Read more
Medical News
Reimagining Fibromyalgia: Neural Networks and Systemic Insights
06/05/2025
Read more

See more news

CME/CE

Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
MinuteCE®
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
1.25 program credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
1.25 program credits
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
MinuteCE®
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
MinuteCE®
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
1.25 program credits
- James R. Bateman, MD, MPH
- Charles P. Vega, MD
- B. Joy Snider, MD, PhD
1.25 program credits
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
MinuteCE®
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
1.25 program credits
- James R. Bateman, MD, MPH
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- Jerome A. Barakos, MD
1.25 program credits

Clinical Practice

Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
NeuroFrontiers
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
- Ahmed Abdelhak, MD
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
NeuroFrontiers
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
- Mary Rensel, MD, FAAN, ABIHM
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
NeuroFrontiers
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
- Jerome Lisk, MD, MBA, M.S., FAAN
- Emile Maamary
- Mark Elias
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiers
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
- Rosaline Quinlivan

Programs

Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
NeuroFrontiers
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
- Riley Bove, MD, MMSc
Debunking gMG Myths: Counseling Strategies That Change the Conversation
Debunking gMG Myths: Counseling Strategies That Change the Conversation
NeuroFrontiers
Debunking gMG Myths: Counseling Strategies That Change the Conversation
- Maxwell H. Levy, MD
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiers
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
- Rosaline Quinlivan
- Ryan Quigley
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis